Healthcare / Medical Care FacilitiesThailand
$7.75
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 19%
FCF escenarios
weak_data · normalized FCF $134.0M · quality 50.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
33/100
D
Piotroski
7/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$13.9B
P/E
86.1x
↑EV/EBITDA
6.5x
↓ROE
0.7%
↑Gross Margin
22.6%
↓Debt/Equity
0.28
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-7.7%
FCF CAGR
-38.4%
FCF margin
3.1%
FCF / Net income
2.98x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $9.10B · net income $96.2M · FCF $286.3M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $9.10B | $9.10B | $9.48B | $9.84B | $11.58B |
| Net Income | $96.2M | $96.2M | $-1.76B | $295.4M | $1.60B |
| EBITDA | $1.83B | $1.83B | $99.4M | $2.08B | $3.34B |
| EPS | 0.08 | 0.08 | -1.96 | 0.31 | 1.67 |
| Gross Margin | 22.6% | 22.6% | 17.8% | 24.9% | 30.1% |
| Operating Margin | 3.5% | 3.5% | -14.3% | 6.0% | 15.2% |
| Net Margin | 1.1% | 1.1% | -18.6% | 3.0% | 13.8% |
| Balance Sheet | |||||
| Debt/Equity | 0.28 | 0.28 | 1.39 | 1.08 | 1.14 |
| Current Ratio | 1.23 | 1.23 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $286.3M | $286.3M | $-336.3M | $134.0M | $1.22B |
| Returns | |||||
| ROE | 0.7% | 0.7% | -24.4% | 3.1% | 16.1% |
| Valuation | |||||
| P/E | 86.11 | 86.11 | — | 211.14 | 40.36 |
| EV/EBITDA | 6.50 | 6.50 | 241.65 | 34.60 | 21.96 |
| P/B | 0.68 | 0.68 | 2.00 | 6.63 | 6.51 |
| Growth & Yield | |||||
| Revenue Growth | -4.0% | -4.0% | -3.7% | -15.0% | — |
| EPS Growth | 104.1% | 104.1% | -734.2% | -81.5% | — |
| Dividend Yield | 1.7% | 1.7% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
104.8%
EPS terminal req.
$0.69
Spread vs growth
-0.8%
5Y implied EPS CAGR
59.7%
EPS terminal req.
$0.83
Spread vs growth
44.3%
10Y implied EPS CAGR
32.6%
EPS terminal req.
$1.34
Spread vs growth
71.5%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-7.1%
Start / end P/E
n/dx → n/dx
EPS bridge
-1.96 → 0.08
Residual
-8.8%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.